245329-78-6
245329-78-6
Chemical Structure
EtDO-P4
- CAS No.: 245329-78-6
- Formula:C31H52N2O4
- Molecular Weight:516.76
IUPAC Name: N-((1R,2R)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)palmitamide
InChIKey: BBTZZVJOQCCAOR-DLFZDVPBSA-N
SMILES: O[C@H](C1=CC=C2C(OCCO2)=C1)[C@H](NC(CCCCCCCCCCCCCCC)=O)CN3CCCC3
Biological Activity: EtDO-P4 is a nanomolar inhibitor of glycosphingolipid (GSL) synthesis. EtDO-P4 suppresses activation of the EGFR-induced ERK pathway and various receptor tyrosine kinases (RTKs). EtDO-P4 can be used for various types of cancer, including Burkitt’s lymphoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
EtDO-P4 | 99.63% | EtDO-P4 is a nanomolar inhibitor of glycosphingolipid (GSL) synthesis. EtDO-P4 suppresses activation of the EGFR-induced ERK pathway and various receptor tyrosine kinases (RTKs). EtDO-P4 can be used for various types of cancer, including Burkitt’s lymphoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
